• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用电子健康记录对亚组化的亚洲和西班牙裔人群进行动脉粥样硬化性心血管疾病风险预测。

Atherosclerotic Cardiovascular Disease Risk Prediction in Disaggregated Asian and Hispanic Subgroups Using Electronic Health Records.

机构信息

1 Division of Cardiovascular Medicine Stanford University School of Medicine Stanford CA.

2 Palo Alto Foundation Research Institute Palo Alto CA.

出版信息

J Am Heart Assoc. 2019 Jul 16;8(14):e011874. doi: 10.1161/JAHA.118.011874. Epub 2019 Jul 11.

DOI:10.1161/JAHA.118.011874
PMID:31291803
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6662141/
Abstract

Background Risk assessment is the cornerstone for atherosclerotic cardiovascular disease ( ASCVD ) treatment decisions. The Pooled Cohort Equations ( PCE ) have not been validated in disaggregated Asian or Hispanic populations, who have heterogeneous cardiovascular risk and outcomes. Methods and Results We used electronic health record data from adults aged 40 to 79 years from a community-based, outpatient healthcare system in northern California between January 1, 2006 and December 31, 2015, without ASCVD and not on statins. We examined the calibration and discrimination of the PCE and recalibrated the equations for disaggregated race/ethnic subgroups. The cohort included 231 622 adults with a mean age of 53.1 (SD 9.7) years and 54.3% women. There were 56 130 Asian (Chinese, Asian Indian, Filipino, Japanese, Vietnamese, and other Asian) and 19 760 Hispanic (Mexican, Puerto Rican, and other Hispanic) patients. There were 2703 events (332 and 189 in Asian and Hispanic patients, respectively) during an average of 3.9 (SD 1.5) years of follow-up. The PCE overestimated risk for NHW s, African Americans, Asians, and Hispanics by 20% to 60%. The extent of overestimation of ASCVD risk varied by disaggregated racial/ethnic subgroups, with a predicted-to-observed ratio of ASCVD events ranging from 1.1 for Puerto Rican patients to 1.9 for Chinese patients. The PCE had adequate discrimination, although it varied significantly by race/ethnic subgroups (C-indices 0.66-0.83). Recalibration of the PCE did not significantly improve its performance. Conclusions Using electronic health record data from a large, real-world population, we found that the PCE generally overestimated ASCVD risk, with marked heterogeneity by disaggregated Asian and Hispanic subgroups.

摘要

背景

风险评估是动脉粥样硬化性心血管疾病(ASCVD)治疗决策的基石。Pooled Cohort Equations(PCE)尚未在亚组亚洲或西班牙裔人群中得到验证,这些人群的心血管风险和结局存在异质性。

方法和结果

我们使用了来自加利福尼亚州北部一个社区为基础的门诊医疗系统的 40 至 79 岁成年人的电子健康记录数据,这些人在研究期间没有 ASCVD 且未服用他汀类药物。我们检查了 PCE 的校准和区分度,并为细分的种族/族裔亚组重新校准了方程。该队列包括 231622 名平均年龄为 53.1(9.7)岁的成年人,其中 54.3%为女性。有 56130 名亚裔(中国人、印度裔、菲律宾人、日本人、越南人和其他亚裔)和 19760 名西班牙裔(墨西哥人、波多黎各人和其他西班牙裔)患者。在平均 3.9(1.5)年的随访中,有 2703 例事件(分别为亚裔和西班牙裔患者中的 332 例和 189 例)。PCE 高估了非西班牙裔白人、非裔美国人、亚洲人和西班牙裔人的风险,高估幅度为 20%至 60%。ASCVD 风险的高估程度因细分的种族/族裔亚组而异,预测到观察到的 ASCVD 事件比值范围从波多黎各患者的 1.1 到中国患者的 1.9。PCE 具有足够的区分度,尽管它因种族/族裔亚组而异(C 指数为 0.66-0.83)。重新校准 PCE 并不能显著提高其性能。

结论

使用来自大型真实世界人群的电子健康记录数据,我们发现 PCE 通常高估了 ASCVD 风险,并且在细分的亚裔和西班牙裔亚组中存在显著的异质性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db05/6662141/2da62823ebc5/JAH3-8-e011874-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db05/6662141/22cd8577483f/JAH3-8-e011874-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db05/6662141/2da62823ebc5/JAH3-8-e011874-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db05/6662141/22cd8577483f/JAH3-8-e011874-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db05/6662141/2da62823ebc5/JAH3-8-e011874-g002.jpg

相似文献

1
Atherosclerotic Cardiovascular Disease Risk Prediction in Disaggregated Asian and Hispanic Subgroups Using Electronic Health Records.利用电子健康记录对亚组化的亚洲和西班牙裔人群进行动脉粥样硬化性心血管疾病风险预测。
J Am Heart Assoc. 2019 Jul 16;8(14):e011874. doi: 10.1161/JAHA.118.011874. Epub 2019 Jul 11.
2
Asthma prevalence in Hispanic and Asian American ethnic subgroups: results from the California Healthy Kids Survey.西班牙裔和亚裔美国人亚组中的哮喘患病率:来自加利福尼亚健康儿童调查的结果。
Pediatrics. 2006 Aug;118(2):e363-70. doi: 10.1542/peds.2005-2687.
3
Patterns and gaps in guideline-directed statin use for atherosclerotic cardiovascular disease by race and ethnicity.按种族和民族划分的、用于动脉粥样硬化性心血管疾病的指南指导他汀类药物使用模式及差距。
Am J Prev Cardiol. 2024 Mar 11;17:100647. doi: 10.1016/j.ajpc.2024.100647. eCollection 2024 Mar.
4
Evaluation of Atherosclerotic Cardiovascular Risk Prediction Models in China: Results From the CHERRY Study.中国动脉粥样硬化性心血管疾病风险预测模型的评估:CHERRY研究结果
JACC Asia. 2022 Jan 4;2(1):33-43. doi: 10.1016/j.jacasi.2021.10.007. eCollection 2022 Feb.
5
[Application of the China-PAR risk prediction model for atherosclerotic cardiovascular disease in a rural northern Chinese population].中国-PAR动脉粥样硬化性心血管疾病风险预测模型在中国北方农村人群中的应用
Beijing Da Xue Xue Bao Yi Xue Ban. 2017 Jun 18;49(3):439-445.
6
Impact of Replacing the Pooled Cohort Equation With Other Cardiovascular Disease Risk Scores on Atherosclerotic Cardiovascular Disease Risk Assessment (from the Multi-Ethnic Study of Atherosclerosis [MESA]).用其他心血管疾病风险评分取代合并队列方程对动脉粥样硬化性心血管疾病风险评估的影响(来自动脉粥样硬化多民族研究 [MESA])
Am J Cardiol. 2016 Sep 1;118(5):691-6. doi: 10.1016/j.amjcard.2016.06.015. Epub 2016 Jun 15.
7
Lipoprotein(a) Levels in Disaggregated Racial and Ethnic Subgroups Across Atherosclerotic Cardiovascular Disease Risk Levels.不同动脉粥样硬化性心血管疾病风险水平下不同种族和族裔亚组的脂蛋白(a)水平。
JACC Adv. 2024 May 2;3(6):100940. doi: 10.1016/j.jacadv.2024.100940. eCollection 2024 Jun.
8
Spectrum of cardiovascular diseases inAsian-American racial/ethnic subgroups.亚裔美国人种族/民族亚群中的心血管疾病谱。
Ann Epidemiol. 2011 Aug;21(8):608-14. doi: 10.1016/j.annepidem.2011.04.004.
9
Risk score overestimation: the impact of individual cardiovascular risk factors and preventive therapies on the performance of the American Heart Association-American College of Cardiology-Atherosclerotic Cardiovascular Disease risk score in a modern multi-ethnic cohort.风险评分高估:个体心血管危险因素及预防性治疗对美国心脏协会 - 美国心脏病学会 - 动脉粥样硬化性心血管疾病风险评分在现代多民族队列中表现的影响
Eur Heart J. 2017 Feb 21;38(8):598-608. doi: 10.1093/eurheartj/ehw301.
10
Hypertension Prevalence in New York City Adults: Unmasking Undetected Racial/Ethnic Variation, NYC HANES 2004.纽约市成年人高血压患病率:揭示未被发现的种族/民族差异,纽约市 HANES 2004 年。
Ethn Dis. 2016 Jul 21;26(3):339-44. doi: 10.18865/ed.26.3.339.

引用本文的文献

1
Hispanic/Latino ethnic background and genetic ancestry in relation to atherosclerotic cardiovascular disease risk estimation: Findings from the Multi-Ethnic Study of Atherosclerosis (MESA).西班牙裔/拉丁裔种族背景与遗传血统与动脉粥样硬化性心血管疾病风险评估的关系:动脉粥样硬化多民族研究(MESA)的发现。
Am J Prev Cardiol. 2025 Aug 22;23:101268. doi: 10.1016/j.ajpc.2025.101268. eCollection 2025 Sep.
2
Population-Level Gaps in Coronary Artery Disease Care: A Focused Review.冠状动脉疾病护理中的人群层面差距:聚焦综述
Methodist Debakey Cardiovasc J. 2025 Aug 12;21(4):76-86. doi: 10.14797/mdcvj.1670. eCollection 2025.
3

本文引用的文献

1
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2018 年美国心脏病学会/美国心脏协会/美国心血管血管造影和介入学会/美国预防、物理治疗和康复医师学会/美国糖尿病协会/美国老年学会/美国药学会/美国医师协会/美国生理学会/北美介入放射学会/美国国家脂质协会/美国临床内分泌医师协会胆固醇管理指南:美国心脏病学会/美国心脏协会临床实践指南工作组的报告。
Circulation. 2019 Jun 18;139(25):e1082-e1143. doi: 10.1161/CIR.0000000000000625. Epub 2018 Nov 10.
2
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2017美国心脏病学会/美国心脏协会/美国医师助理学会/美国心脏病学学会/美国预防医学学院/美国老年病学会/美国药剂师协会/美国血液学会/美国预防心脏病学会/美国国家医学协会/美国初级保健医师学会成人高血压预防、检测、评估和管理指南:执行摘要:美国心脏病学会/美国心脏协会临床实践指南工作组报告
Circulation. 2018 Oct 23;138(17):e426-e483. doi: 10.1161/CIR.0000000000000597.
Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) Equations: What Clinicians Need to Know?
预测心血管疾病事件风险(PREVENT)方程:临床医生需要了解什么?
Curr Atheroscler Rep. 2025 Jul 21;27(1):73. doi: 10.1007/s11883-025-01320-z.
4
Performance of the American Heart Association's PREVENT Equations Among Disaggregated Racial and Ethnic Subgroups.美国心脏协会预防方程在不同种族和族裔亚组中的表现。
JAMA Cardiol. 2025 Jun 25. doi: 10.1001/jamacardio.2025.1865.
5
Differences in Coronary Heart Disease and Stroke Incidence Among Single-Race and Multiracial Asian and Pacific Islander Subgroups in Hawaii and California: A Retrospective Cohort Study.夏威夷和加利福尼亚单一种族及多种族亚裔和太平洋岛民亚组中心脏病和中风发病率的差异:一项回顾性队列研究。
J Am Heart Assoc. 2025 May 6;14(9):e039076. doi: 10.1161/JAHA.124.039076. Epub 2025 Apr 16.
6
Association of mid-life cardiovascular risk with biomarkers of Alzheimer's disease, neurodegeneration, and white matter hyperintensities: Heart SCORE brain study.中年心血管风险与阿尔茨海默病、神经退行性变及脑白质高信号生物标志物的关联:心脏SCORE脑研究
J Alzheimers Dis Rep. 2025 Jan 15;9:25424823241299297. doi: 10.1177/25424823241299297. eCollection 2025 Jan-Dec.
7
Artificial Intelligence in Ischemic Heart Disease Prevention.人工智能在缺血性心脏病预防中的应用
Curr Cardiol Rep. 2025 Feb 1;27(1):44. doi: 10.1007/s11886-025-02203-0.
8
2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association.《2025年心脏病和中风统计数据:美国心脏协会关于美国和全球数据的报告》
Circulation. 2025 Feb 25;151(8):e41-e660. doi: 10.1161/CIR.0000000000001303. Epub 2025 Jan 27.
9
Electrical Heterogeneity in Hispanic Background Subpopulations: The HCHS/SOL.西班牙裔背景亚人群中的电不均一性:西班牙裔社区健康研究/拉丁裔研究(HCHS/SOL)
JACC Adv. 2024 Sep 11;3(12):101225. doi: 10.1016/j.jacadv.2024.101225. eCollection 2024 Dec.
10
Risk-enhancing factors and social determinants of health in risk assessment for atherosclerotic cardiovascular disease.动脉粥样硬化性心血管疾病风险评估中的风险增强因素和健康的社会决定因素。
PLoS One. 2024 Oct 25;19(10):e0312756. doi: 10.1371/journal.pone.0312756. eCollection 2024.
3
Evaluation of the Pooled Cohort Risk Equations for Cardiovascular Risk Prediction in a Multiethnic Cohort From the Women's Health Initiative.在女性健康倡议的多民族队列中评估用于心血管风险预测的合并队列风险方程。
JAMA Intern Med. 2018 Sep 1;178(9):1231-1240. doi: 10.1001/jamainternmed.2018.2875.
4
Clinical Implications of Revised Pooled Cohort Equations for Estimating Atherosclerotic Cardiovascular Disease Risk.修订后的汇总队列方程在估计动脉粥样硬化性心血管疾病风险中的临床意义。
Ann Intern Med. 2018 Jul 3;169(1):20-29. doi: 10.7326/M17-3011. Epub 2018 Jun 5.
5
Cardiovascular disease risk prediction equations in 400 000 primary care patients in New Zealand: a derivation and validation study.新西兰 40 万例初级保健患者的心血管疾病风险预测方程:一项推导和验证研究。
Lancet. 2018 May 12;391(10133):1897-1907. doi: 10.1016/S0140-6736(18)30664-0. Epub 2018 May 4.
6
Thyroid cancer mortality is higher in Filipinos in the United States: An analysis using national mortality records from 2003 through 2012.在美国的菲律宾人中,甲状腺癌死亡率更高:一项使用2003年至2012年国家死亡率记录的分析。
Cancer. 2017 Dec 15;123(24):4860-4867. doi: 10.1002/cncr.30958. Epub 2017 Sep 7.
7
Use and Customization of Risk Scores for Predicting Cardiovascular Events Using Electronic Health Record Data.利用电子健康记录数据的风险评分的使用和定制来预测心血管事件。
J Am Heart Assoc. 2017 Apr 24;6(4):e003670. doi: 10.1161/JAHA.116.003670.
8
Disaggregation of Cause-Specific Cardiovascular Disease Mortality Among Hispanic Subgroups.西班牙裔亚组特定原因心血管疾病死亡率的分解。
JAMA Cardiol. 2017 Mar 1;2(3):240-247. doi: 10.1001/jamacardio.2016.4653.
9
Mortality outcomes for Chinese and Japanese immigrants in the USA and countries of origin (Hong Kong, Japan): a comparative analysis using national mortality records from 2003 to 2011.美国以及原籍国(中国香港、日本)的中国和日本移民的死亡率结果:一项使用2003年至2011年国家死亡率记录的比较分析。
BMJ Open. 2016 Oct 28;6(10):e012201. doi: 10.1136/bmjopen-2016-012201.
10
Calibration of the Pooled Cohort Equations for Atherosclerotic Cardiovascular Disease: An Update.动脉粥样硬化性心血管疾病 pooled 队列方程的校准:更新。
Ann Intern Med. 2016 Dec 6;165(11):786-794. doi: 10.7326/M16-1739. Epub 2016 Oct 11.